SCHEMBL4927573

SCHEMBL4927573

CCOC(=O)c1ccc(Cc2cc(Cl)ccc2OC(CC)CC)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.52
ALDH1A1 P00352 6/20 0.49
GAA P10253 1/20 0.49
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
POLB P06746 3/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAOB P27338 1/20 0.43
MAPT P10636 5/20 0.42
LMNA P02545 3/20 0.42
KDM4E B2RXH2 3/20 0.41
TSHR P16473 3/20 0.41
HPGD P15428 2/20 0.41
ALOX15 P16050 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 2/20 0.41
HSP90AA1 P07900 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923327 0.90 PTGER1 (0.55) PTGER1ALDH1A1GAAMEN1KMT2A
SCHEMBL14008066 0.88 PTGER1 (0.54) PTGER1ALDH1A1GAAMEN1KMT2A
SCHEMBL3223740 0.86 ALDH1A1 (0.53) PTGER1ALDH1A1GAAMEN1KMT2A
SCHEMBL4920368 0.86 PTGER1 (0.70) PTGER1GAAMEN1KMT2APOLB
SCHEMBL4915825 0.85 PTGER1 (0.60) PTGER1ALDH1A1GAAMEN1KMT2A
SCHEMBL4765586 0.84 PTGER1 (0.74) PTGER1ALDH1A1GAANPC1RAB9A
SCHEMBL4923927 0.83 PTGER1 (0.55) PTGER1ALDH1A1GAAMEN1KMT2A
SCHEMBL4922863 0.83 PTGER1 (0.49) PTGER1ALDH1A1GAAMEN1KMT2A
SCHEMBL4929045 0.82 PTGER1 (0.60) PTGER1ALDH1A1GAAMEN1KMT2A
SCHEMBL4918681 0.82 PTGER1 (0.59) PTGER1ALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists PTGER1, PTGER2, PTGER3 PTGER1 1/4885ALDH1A1 1015/4885GAA 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.